Michael Magro

Coronary interventions

Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities

Simsek C, Karanasos A, Magro M, Garcia-Garcia H, Onuma Y, Regar E, Boersma E, Serruys P, van Geuns R

January 20, 2016 | 10.4244/EIJY14M10_12

Differences in coronary risk factors, procedural characteristics, mortality and stent thrombosis between two all-comers percutaneous coronary intervention registries from Europe and Japan: a patient-level data analysis of the Bern-Rotterdam and j-Cypher registries

Onuma Y, Kimura T, Räber L, Magro M, Girasis C, van Domburg R, Windecker S, Mitsudo K, Serruys P

September 22, 2015 | 10.4244/EIJY14M06_09

Coronary interventions

Dedicated stents for distal left main stenting

Grundeken M.J, Magro M, Gil R, Briguori C, Sardella G, Berland J, Wykrzykowska J, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA29

Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH)

Simsek C, Magro M, Onuma Y, Boersma E, Smits P, Dorange C, Veldhof S, Regar E, Serruys P, van Geuns R

June 20, 2014 | 10.4244/EIJV10I2A38

Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein grafts

Taniwaki M, Räber L, Magro M, Kalesan B, Onuma Y, Stefanini G, van Domburg R, Moschovitis A, Meier B, Jüni P, Serruys P, Windecker S

April 22, 2014 | 10.4244/EIJV9I12A241

The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy

Farooq V, Girasis C, Magro M, Onuma Y, Morel M, Heo J, Garcia-Garcia H, Kappetein AP, van den Brand M, Holmes DR, Mack M, Feldman T, Colombo A, Stahle E, James S, Carrié D, Fournial G, Van Es G-A, Dawkins K, Mohr F, Morice M, Serruys P

December 27, 2013 | 10.4244/EIJV9I8A170

Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry

Magro M, Girasis C, Bartorelli A, Tarantini G, Russo F, Trabattoni D, D’Amico G, Galli M, Juame A, de Sousa Almeida M, Simsek C, Foley DP, Sonck J, Lesiak M, Kayaert P, Serruys P, van Geuns R

March 22, 2013 | 10.4244/EIJV8I11A194

The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy

Farooq V, Girasis C, Magro M, Onuma Y, Morel M, Heo J, Garcia-Garcia H, Kappetein AP, van den Brand M, Holmes DR, Mack M, Feldman T, Colombo A, Stahle E, James S, Carrié D, Fournial G, Van Es G-A, Dawkins K, Mohr F, Morice M, Serruys P

March 22, 2013 | 10.4244/EIJV8I11A196

The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3)

Simsek C, Garcia-Garcia H, van Geuns R, Magro M, Girasis C, Van Mieghem N, Lenzen M, de Boer S, Regar E, van der Giessen WJ, Raichlen J, Duckers H, Zijlstra F, van der Steen A, Boersma E, Serruys P

June 27, 2012 | 10.4244/EIJV8I2A37

Magnetic navigation system assisted stenting of coronary bifurcation lesions

Simsek C, Magro M, Patterson M, Onuma Y, Ciampichetti I, van Weenen S, van Domburg R, Serruys P, Boersma E, van Geuns R

March 21, 2011

The Tryton Side Branch Stent

Magro M, van Geuns R

January 11, 2011

Computed tomography as a tool for percutaneous coronary intervention of chronic total occlusions

Magro M, Schultz C, Simsek C, Garcia-Garcia H, Regar E, Nieman K, Mollet N, Serruys P, van Geuns R

May 25, 2010

Transferability of data between different drug-eluting stents

Magro M, Onuma Y, Silber S, Serruys P

November 15, 2009 | 10.4244/EIJV5I5A85

Michael Magro

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke